You manage large volumes of medical content across multiple markets.
Maybe you’re a medical publisher with patient information sheets that need updating after every regulatory change. Maybe you’re a digital therapeutics platform, and a single algorithm update cascades into 26 language versions. Or maybe you’re a patient engagement platform serving multicultural populations who need culturally adapted content, not just translated text.
Human translation offers high-quality cultural adaptation and accuracy, but it can be a slow process when it’s done at scale. For large volumes, turnaround times can stretch to 6–8 weeks per language pair, and that slows down your content updates.
On the other hand, many generic AI translation tools promise speed, but they lack full transparency. You don’t know which model version processed your content; you can’t audit what data trained it; and, crucially, your content leaves your infrastructure and goes to external servers – creating questions around data sovereignty that most compliance teams can’t answer.
The perfect middle ground between these two approaches? Custom machine translation, but only when it’s implemented with appropriate validation processes.
The Volume Scaling Problem
Companies with high volumes of healthcare content face a specific challenge: they need both speed and compliance.
That causes tension, because human translation delivers quality but can’t scale. Six weeks per language pair means that updates to hundreds of documents across five languages become months of sequential work. So, as a result, your content is outdated before it’s even been published.
At the other end of the scale, generic AI translation is fast but creates new risks, as off-the-shelf tools still present fundamental challenges:
The black box problem: You can’t verify which specific model version processed your content or what data was used to train it.
Data sovereignty: Your content leaves your infrastructure and is processed on external servers.
Auditability gaps: When compliance teams ask, “How was this translated?” you can’t provide the documentation trail they need.
Terminology drift: Terminology consistency becomes harder to maintain without dedicated controls and domain adaptation.
When you scale up – from 50 documents to 500, or from 3 language pairs to 12 – these problems compound and become version control nightmares across 100,000+ segments, terminology inconsistencies that create compliance risk, and having no clear answer to provide when you’re asked, “Where did patient data go during translation?”
What Custom MT Actually Means
Custom machine translation is much more than just “using AI for assistance.” It’s training an engine specifically on your content library and deploying it within your infrastructure.
The critical difference is that generic MT systems are trained on broad, mixed-domain datasets, which may not reflect your specific terminology or conventions. They know general medical language, but not your approved terminology, stylistic conventions, IFU formats, and regulatory patterns (EMA/ANSM/FDA), and they’re processed on servers you don’t control.
On the other hand, in some setups, custom MT can be deployed within your own infrastructure or a controlled environment. This means your training data doesn’t leave your environment, and the model belongs to you, so you control updates, versioning, and access.
When you need to update hundreds of documents (measured in segments – typically 15,000+ segments for content platforms with recurring translation needs), the engine generates first drafts in a matter of hours rather than a matter of weeks. Those drafts already reflect your established terminology patterns and maintain consistency across your entire content library.
The Critical Part: Expert Validation
AI can accelerate the draft generation process, and the speed gains from custom MT are real, but domain expertise remains essential for validation. Regulated healthcare content demands expert human validation – always.
Different content types require different approaches:
- Patient-facing materials need native medical translators to validate clinical accuracy and ensure cultural comprehension and plain language readability.
- Technical documentation requires specialists who understand both the medical domain and the regulatory context.
- And regulatory submissions demand documented validation workflows that satisfy compliance requirements.
Here’s how this works in practice:
Imagine a medical publisher facing regulatory updates affecting hundreds of patient information sheets across 8 languages. Manual translation would take months, but using generic AI would introduce terminology inconsistencies that the editorial team can’t accept.
A custom MT approach generates consistent first drafts based on the publisher’s approved terminology and established style patterns, and then medical translators and native reviewers validate clinical accuracy and cultural appropriateness. The documented workflow provides the audit trail the compliance team needs.
When Custom MT Makes Sense
Technical threshold for meaningful domain adaptation: 10,000–50,000 segments when fine-tuning a pre-trained model (not training from scratch). Smaller specialized corpora (5,000+) can offer measurable gains for highly repetitive regulated content.
Business justification threshold: 10,000+ segments with recurring update cycles. At this point, the savings of MTPE and TM leverage exceed the costs of custom engine development and validation. This threshold varies significantly depending on language pair, domain specificity, and regulatory compliance requirements.
Custom MT isn’t always the right fit. Here’s the framework to help you make a decision.
Custom MT makes sense when you have:
- High volume (for example, 15,000+ segments across multiple document types – business justification)
- Multiple language pairs (5+ target languages)
- Recurring updates (algorithm changes, guideline revisions, continuous content publishing)
- Consistency requirements (regulatory compliance, brand terminology, style standards)
- Data sovereignty concerns (content cannot leave your infrastructure)
Custom MT may NOT make sense when:
- Low volume (under 5,000 segments, infrequent updates)
- Highly variable content with no consistent patterns to learn from
- Simple, non-regulated content which generic tools could be suitable for
- One-off projects without ongoing content management needs
Red Flags When Evaluating Partners
If you’re exploring custom MT implementation, watch for these warning signs from providers:
- “We use AI for assistance,” without being able to specify the model, version, or training data – that introduces a lack of transparency into your compliance chain.
- Can’t explain where your data is processed – if content leaves your infrastructure without clear documentation, you have a data sovereignty problem.
- “One engine serves all clients” – that’s shared infrastructure, not custom training on your specific content.
- No documented validation workflow – audit trails matter when compliance teams ask questions.
Building Infrastructure That Scales
Scaling multilingual medical content requires careful evaluation of where AI can accelerate work and where expert human judgment remains essential.
Custom MT can handle first-draft generation for high-volume content. Then, qualified specialists validate clinical accuracy, cultural appropriateness, and regulatory compliance, and documented workflows provide the audit trails compliance teams need.
At ArtLingua, we implement exactly these workflows for healthcare content platforms – combining custom MT deployment with 26 years of medical translation expertise and a network of specialist validators who understand what’s at stake in regulated content.
If you’re managing high-volume medical content across multiple markets and wondering whether custom MT makes sense for your specific situation, let’s discuss what responsible implementation would look like for your content workflow.
Contact us to schedule a workflow assessment consultation.
